It helps: The body release insulin when blood sugar is high
Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures
Semaglutide users preparing for surgery face a critical decision: when and how to pause treatment
But within those medications, there is an important distinction: standard-dose protocols are designed for stronger appetite suppression and more traditional weight loss titration, while microdose protocols use lower-dose strategies intended to be gentler, more gradual, and often easier to tolerate
Sales of the companys current blockbuster weight loss drug, Wegovy, continued to soar in the third quarter, surpassing Wall Street expectations
Among patients with PCOS, 55.7% of those prescribed a GLP-1 lost at least 10% of their body weight, compared to just 13.7% of those prescribed metformin